Publisert 29.11.2018

Notification of grant:Divisional EPO patent

Notification of grant: Divisional EPO patent

 

Regenics have recieved notification from the European Patent Office on November 22nd 2018 of EPOs granting of  a Decision to Grant from the European Patent Office for the EP Patent Application No. 12178381.5    Divisional of EP Patent Application No. 07825530.4

Entitled: ADMINISTRATION OF CELLS  AND CELLULAR EXTRACTS FOR REJUVENATION

The application will grant on December 19, 2018 as EP Patent Number 

2656832.

Additional info on our other EPO patents: EP 2296676.  09742464.2

For more information, please contact Henrik Lund, CEO

 

Regenics AS has developed a number of assays and techniques to study effects of various substances on skin cells both in vitroin vivo and in the clinic. Our focus is to develop products and techniques for therapeutic skin applications and to improve skin appearance.